143 related articles for article (PubMed ID: 3053436)
21. Injection sclerotherapy of esophageal varices using ethanolamine oleate.
Hedberg SE; Fowler DL; Ryan RL
Am J Surg; 1982 Apr; 143(4):426-31. PubMed ID: 6978620
[TBL] [Abstract][Full Text] [Related]
22. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.
Kanagawa H; Mima S; Kouyama H; Gotoh K; Uchida T; Okuda K
J Gastroenterol Hepatol; 1996 Jan; 11(1):51-8. PubMed ID: 8672742
[TBL] [Abstract][Full Text] [Related]
23. Treatment of gastric fundal varices by balloon endoscopic sclerotherapy.
Hamamoto N; Matsumoto A; Nomura T; Kayazawa M; Hirata I; Morikawa H; Katsu K
Gastrointest Endosc; 1999 Jan; 49(1):115-8. PubMed ID: 9869737
[No Abstract] [Full Text] [Related]
24. Sclerotherapy for gastric fundal variceal bleeding: is complete obliteration possible without cyanoacrylate?
Kojima K; Imazu H; Matsumura M; Honda Y; Umemoto N; Moriyasu H; Orihashi T; Uejima M; Morioka C; Komeda Y; Uemura M; Yoshiji H; Fukui H
J Gastroenterol Hepatol; 2005 Nov; 20(11):1701-6. PubMed ID: 16246189
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease.
el-Zayadi A; el-Din SS; Kabil SM
Gastrointest Endosc; 1988; 34(4):314-7. PubMed ID: 3044913
[TBL] [Abstract][Full Text] [Related]
26. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
[TBL] [Abstract][Full Text] [Related]
27. New transjugular retrograde obliteration without the use of ethanolamine oleate for gastric varices.
Chikamori F; Okamoto H; Kuniyoshi N
Surg Laparosc Endosc Percutan Tech; 2015 Feb; 25(1):e27-e32. PubMed ID: 24743676
[TBL] [Abstract][Full Text] [Related]
28. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
29. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal.
Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K
Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718
[TBL] [Abstract][Full Text] [Related]
30. A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction.
Kahn D; Krige JE; Terblanche J; Bornman PC; Robson SC
Ann Surg; 1994 Jan; 219(1):34-9. PubMed ID: 8297173
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating effect of sclerosant concentration.
Dowidar N; Hafez A
J Egypt Soc Parasitol; 2002 Aug; 32(2):537-49. PubMed ID: 12214931
[TBL] [Abstract][Full Text] [Related]
32. [Sclerotherapy of esophageal varices: a prospective study].
Maggiolo P; Ribalta J; Klinger J
Rev Med Chil; 1988 Oct; 116(10):1013-8. PubMed ID: 3267876
[No Abstract] [Full Text] [Related]
33. Immediate endoscopic injection therapy of bleeding oesophageal varices: a prospective comparative evaluation of injecting materials in Egyptian patients with portal hypertension.
Omar MM; Fakhry SM; Mostafa I
J Egypt Soc Parasitol; 1998 Apr; 28(1):159-68. PubMed ID: 9617052
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic sclerotherapy of esophageal varices.
Novis B; Bat L; Pomerantz I; Shemesh E
Isr J Med Sci; 1983 Jan; 19(1):40-4. PubMed ID: 6601090
[No Abstract] [Full Text] [Related]
35. Transjugular retrograde obliteration for gastric varices.
Chikamori F; Shibuya S; Takase Y; Ozaki A; Fukao K
Abdom Imaging; 1996; 21(4):299-303. PubMed ID: 8661570
[TBL] [Abstract][Full Text] [Related]
36. Influence of hepatic reserve and cause of esophageal varices on survival and rebleeding before and after the introduction of sclerotherapy: a retrospective analysis.
DiMagno EP; Zinsmeister AR; Larson DE; Viggiano TR; Clain JE; Laughlin BL; Hughes RW
Mayo Clin Proc; 1985 Mar; 60(3):149-57. PubMed ID: 3871884
[TBL] [Abstract][Full Text] [Related]
37. Suction sclerotherapy for the treatment of esophageal varices.
Blackard WG; Marks RD; Baron TH
Gastrointest Endosc; 1996 Dec; 44(6):725-8. PubMed ID: 8979066
[No Abstract] [Full Text] [Related]
38. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate.
Neeman A; Leiser A; Kadish U
Am J Gastroenterol; 1991 Sep; 86(9):1182-4. PubMed ID: 1882797
[TBL] [Abstract][Full Text] [Related]
39. Sclerotherapy in the treatment of bleeding oesophageal varices: preliminary report.
Lule GN; Ogutu EO; Okoth F; Were JB; Wambugu M
East Afr Med J; 1988 Jun; 65(6):416-20. PubMed ID: 3053146
[No Abstract] [Full Text] [Related]
40. Balloon-occluded retrograde transvenous obliteration of a gastric varix via the left inferior phrenic vein.
Matsumoto T; Yamagami T; Nakamura N; Kato T; Hirota T; Yoshimatsu R; Nishimura T
Br J Radiol; 2008 Oct; 81(970):e246-8. PubMed ID: 18796552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
